Insider filing · PVLA
George M Jenkins
Director
profile →
Palvella Therapeutics, Inc.
PVLA · Healthcare · 16 filings in 24 months
ticker →
George M Jenkins sold $3.3M of Palvella Therapeutics (PVLA)
Executed Oct 12, disclosed Oct 14, 2 days later.
Value, as filed
$3.3M
25,343 sh across 13 lots
Executed
Oct 12
the trade date, as filed
Disclosed
Oct 14
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
GJGeorge M Jenkins (Director) filed 3 Form 4 reports in the trailing twelve months (1 purchase, 2 sales), most often in Palvella Therapeutics, Inc. (PVLA). Across 1 priced purchase filing, the average 21-session return was -23.3% from execution and -21.8% from disclosure (delay-adjusted; derived). The largest single filing was $4.0M of PVLA (26,677 sh across 7 lots, as filed), executed Sep 11.
The name
PVLAHealthcare · Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by George M Jenkins in PVLA
PVLASALE
Palvella Therapeutics, Inc.
$4.0M26,677 sh across 7 lots
Exec Sep 11
Filed Sep 15 · 9:15 PM ET PVLAPURCHASE Palvella Therapeutics, Inc. $500K
4,000 sh × $125.00
Exec Feb 27
Filed Mar 2 · 8:00 AM ET